Empagliflozin plus loop diuretics significantly increase urine volume in diabetes with HF Medha Baranwal10 Nov 2020 10:15 AM ISTUK: The use of SGLT2 inhibitor empagliflozin in combination with loop diuretics in patients with type 2 diabetes (T2D) and heart failure, helps in...
Fat loss, not weight loss reduces heart failure risk: Circulation study Dr. Kamal Kant Kohli10 Nov 2020 5:37 AM ISTDALLAS - Being overweight and obese are strong risk factors for both type 2 diabetes and heart disease, and patients are often counseled to lose...
Triptans safe for heart of migraine patients, finds study Medha Baranwal2 Nov 2020 10:15 PM ISTUSA: Results from a recent study provide reassurance about triptans being cardiovascular safe for use in people with migraine headaches. According to...
Night time high BP linked to heart failure risk: Circulation study Dr. Kamal Kant Kohli2 Nov 2020 5:25 PM ISTDALLAS - Typically office and daytime blood pressure measurements are used by Health care professionals to determine needs and dosages of patient's...
COVID-19 in Heart Failure patients tied to increased risk of death and intubation Hina Zahid30 Oct 2020 4:00 PM ISTBottom Line: Mount Sinai researchers found that COVID-19 patients with a history of heart failure were associated with a longer duration of...
Ketogenic diets could prevent, reverse heart failure, claims study Hina Zahid28 Oct 2020 6:30 PM ISTST. LOUIS - Research from Saint Louis University finds that high fat or "ketogenic" diets could completely prevent, or even reverse heart failure...
Emerging treatment helps reverse chronic heart failure: Circulation study Dr. Kamal Kant Kohli26 Oct 2020 6:00 PM ISTResearchers have found in a prospective multicenter non-randomized study (RESTAGE-HF) that an emerging heart failure treatment could potentially...
Empagliflozin may reduce hospitalization and death risk in heart failure: Study Dr Satabdi Saha26 Oct 2020 8:00 AM ISTAccording to a recent research, patients receiving empagliflozin therapy for heart failure, showed a lower risk of cardiovascular death or...
Empagliflozin lowers death risk in HF in non Diabetics also: NEJM Medha Baranwal17 Oct 2020 10:30 AM ISTUSA: The use of SGLT2 inhibitor empagliflozin in heart failure patients lowers the risk of cardiovascular death and hospitalization for...
Beta Blockers reduce Mortality in Heart Failure Patients with CKD, claims study Dr Kartikeya Kohli13 Oct 2020 11:05 AM ISTCurrent national guidelines recommend that clinicians treat patients with heart failure and left ventricular systolic dysfunction with β-adrenergic...
Admission serum chloride levels prognostic markers for Heart failure, finds study. Dr.Niharika Harsha B12 Oct 2020 10:00 AM ISTRecent studies have shown that lower serum chloride level is associated with diuretic resistance and increased mortality in heart failure. Impact of...
SGLT2 inhibitors improve survival and renal outcomes in heart failure: Lancet Medha Baranwal16 Sept 2020 7:50 AM ISTFrance: Treatment with empagliflozin and dapagliflozin reduces all-cause mortality and improves renal outcomes in patients with heart failure with...
